# EDGAR Filing Document

**Accession Number:** 0001843588
**File Stem:** 0001213900-26-057127
**Filing Date:** 2026-5
**Character Count:** 20626
**Document Hash:** 9c8568cf11fa798c403c892d7a3f3bc3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-057127.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001213900-26-057127

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260515

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REE Automotive Ltd.
- **CENTRAL INDEX KEY:** 0001843588
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLES & PASSENGER CAR BODIES [3711]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40649
- **FILM NUMBER:** 26982200

**BUSINESS ADDRESS:**
- **STREET 1:** KIBBUTZ GLIL-YAM
- **CITY:** KIBBUTZ GLIL-YAM
- **STATE:** L3
- **ZIP:** 4690500
- **BUSINESS PHONE:** 954 907 2231

**MAIL ADDRESS:**
- **STREET 1:** KIBBUTZ GLIL-YAM
- **CITY:** KIBBUTZ GLIL-YAM
- **STATE:** L3
- **ZIP:** 4690500

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of May 2026

Commission File Number: 001-40649

**REE AUTOMOTIVE LTD.**

**(Exact name of registrant as specified in its charter)**

Kibbutz Glil-Yam

4690500, Israel

**(Address of principal executive office)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

**EXPLANATORY NOTE**

On May 15, 2026, REE Automotive Ltd. (the "Company") announced its financial results for the fiscal year ended December 31, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.

The information in this Report on Form 6-K is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Press Release of REE Automotive Ltd., dated May 15, 2026](ea029083701ex99-1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **REE AUTOMOTIVE LTD.** | **REE AUTOMOTIVE LTD.** |
| By: | /s/ Avital Futterman |
| Name: | Avital Futterman |
| Title: | General Counsel |

---

Date: May 15, 2026

## Exhibit 99.1

**Exhibit 99.1**

**REE Automotive Announces Fiscal Year 2025 Financial Results**

**TEL AVIV, Israel, May 15, 2026** – REE Automotive Ltd. (Nasdaq: REE) ("REE" or the "Company"), an automotive technology company that develops and builds software-defined vehicle technology, today announced its financial results for the fiscal year ended December 31, 2025.

During 2025, we grew our engagement with industry leaders such as Mitsubishi Fuso Truck and Bus Corporation, a Japanese manufacturer of trucks and buses and a subsidiary of Archion since 2026 and others. In addition, as part of our announced production pause and shift to being a software-led business, we took significant actions to reduce our net operating expenses, including through a 40% reductions-in-force as of year-end 2025, which lowered our research and development payroll expenses by approximately $2.6 million and our selling, general, and administrative payroll expenses by approximately $2.7 million YoY. This excludes one-time termination costs associated with our reductions-in-force, which totaled approximately $2.1 million.

Additionally, following our production pause, we decreased our outstanding 2025 and future production-related commitments with our suppliers from approximately $42 million to approximately $13 million. Through these and other actions, we reduced the Company's future cash obligations and further streamlined our operating expenses. As a result, our non-Generally Accepted Accounting Principles (GAAP) net loss for 2025 decreased by 18%, from $70 million for the year ended 2024, to $58 million for the year ended 2025.

"We continue to believe that REE's technology, engineering capabilities and intellectual property portfolio represent meaningful strategic value, and we remain focused on evaluating strategic alternatives and opportunities for the business," said Daniel Barel, REE's CEO and co-founder.

**<u>2025 Year-End Financial Results and Recent Highlights</u>**

● Cash & cash equivalents were $14.2 million as of December 31, 2025, compared to $54.3 million (excluding a credit facility of $18 million, which expired at year-end 2025) in cash & cash equivalents as of December 31, 2024. As of May 4, 2026, our cash and cash equivalents were $4.9 million.

● Free Cash Flow (FCF) burn decreased year-over-year (YoY) by $1.5 million or 2%, from $76.5 million for the year ended December 31, 2024 to $75.0 million for the year ended December 31, 2025. The decrease was primarily due to the cost-reduction-plan announced in June 2025 and was partially offset by production-related costs incurred prior to the pause in production, which mainly related to inventory purchases for the P7 program, a lower UK R&D tax credits YoY, and the absence in 2025 of UK APC grants that were previously received in 2024.

● GAAP net loss decreased by approximately 50%, from $111.8 million for the year ended December 31, 2024 to $55.8 million for the year ended December 31, 2025. The YoY improvement was primarily driven by non-cash income from the remeasurement of warrants and derivative liabilities following a decrease in REE's share price in 2025 as well as by savings realized in connection with our cost-reduction-plan and the related reduction-in-force. These improvements were partially offset by non-cash inventory write-downs and impairment of long-lived assets related to the pause in production, a lower UK R&D tax credits YoY, and the absence in 2025 of UK APC grants that were previously received in 2024.

● Non-GAAP net loss decreased by approximately 18%, from $70.3 million for the year ended December 31, 2024, to $57.7 million for the year ended December 31, 2025. The YoY improvement was primarily driven by savings in connection with our cost-reduction plan and the reduction-in-force thereunder. These savings were partially offset by lower UK R&D tax credits YoY and the absence in 2025 of UK APC grants that were previously received in 2024.

● Subsequently, in the fourth quarter 2025, the Company began engaging with counterparties regarding strategic alternatives intended to maximize shareholder value and it engaged TD Securities (USA) LLC as its financial advisor to assist it in its strategic review process.

The Company continues to evaluate measures intended to preserve liquidity and maximize shareholder value, including additional operational cost reductions and strategic alternatives.

A reconciliation of GAAP to non-GAAP measures has been provided in the financial statement tables included in this press release. An explanation of these measures is also included below under the heading "Non-GAAP Financial Measures."

**Non-GAAP Financial Measures**

We have provided financial information in this press release that has not been prepared in accordance with GAAP. These non-GAAP financial measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similar measures presented by other companies. We use these non-GAAP financial measures internally in analyzing our financial results and believe they are useful to investors, as a supplement to GAAP measures, in evaluating our ongoing operational performance. We believe that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial results with peer companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures provided in the financial statement tables below.

We believe that Free Cash Flow (FCF) to be a liquidity measure that provides useful information to management and investors about the amount of cash used in our operational activities and capital expenditures. Free Cash flow burn represents the negative cash outflow used in our operating activities and for purchases of property and equipment.

We believe that non-GAAP net loss reflects an additional means of evaluating REE's ongoing operating results and trends. We believe that this non-GAAP measure provides useful information about our operating results, enhances the overall understanding of our past performance and future prospects and allows for greater visibility with respect to key metrics used by our management in its financial and operational decision-making.

**About REE Automotive**

**Caution About Forward-Looking Statements**

This press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include, among others, statements about the Company's evaluation of methods to preserve liquidity and maximize shareholder value, including operational cost reductions and strategic alternatives. Actual results of matters addressed in these forward-looking statements involve risks and uncertainties and may differ substantially from those expressed or implied. Factors that could cause actual results to differ are discussed in the sections entitled "Cautionary Note Regarding Forward-Looking Statements", "Risk Factors", and "Operating and Financial Review and Prospects" in REE's annual report filed with the U.S. Securities and Exchange Commission (the "SEC") on May 15, 2026, as updated by the REE's subsequent filings with the SEC. The forward-looking statements in this press release speak only as of the date of this press release, and we undertake no obligation to update any forward-looking statements.

**REE AUTOMOTIVE LTD.**

**Condensed Consolidated Statements of Comprehensive Loss**

**U.S. dollars in thousands (except share and per share data) (Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Twelve Months Ended** | **Twelve Months Ended** |
|  | **December 31,**<br>**2025** | **December 31,**<br>**2024** |
| Revenues | $1297 | $183 |
| Cost of revenues | 17571 | 3681 |
| **Gross loss** | $**(16274)** | $**(3498)** |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;Research and development expenses, net | 45432 | 49460 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 19988 | 26171 |
| &nbsp;&nbsp;&nbsp;Other expenses | 24716 |  |
| Total operating expenses | 90136 | 75631 |
| **Operating loss** | $**(106410)** | $**(79129)** |
| &nbsp;&nbsp;&nbsp;Income (Loss) from warrants remeasurement | 37953 | (22750) |
| &nbsp;&nbsp;&nbsp;Financial income (expenses), net | 10658 | (7812) |
| Net loss before income tax | (57799) | (109691) |
| &nbsp;&nbsp;&nbsp;Taxes on income (tax benefit) | (1992) | 2063 |
| Net loss | $**(55807)** | $**(111754)** |
| **Net comprehensive loss** | $**(55807)** | $**(111754)** |
| **Basic and diluted net loss per Class A ordinary share** | $**(1.74)** | $**(7.01)** |
| Weighted average number of ordinary shares used in computing basic and diluted net loss per share | 32140321 | 15933291 |

---

**REE AUTOMOTIVE LTD.**

**Condensed Consolidated Balance Sheets**

**U.S. dollars in thousands (except share and per share data) (Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **December 31,<br> 2025** | **December 31,<br> 2024** |
| **ASSETS** |  |  |
| CURRENT ASSETS: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $14246 | $72262 |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 24 | 11 |
| &nbsp;&nbsp;&nbsp;Inventory |  | 3075 |
| &nbsp;&nbsp;&nbsp;Other accounts receivable and prepaid expenses | 691 | 7158 |
| Total current assets | 14961 | 82506 |
| NON-CURRENT ASSETS: |  |  |
| &nbsp;&nbsp;&nbsp;Non-current restricted cash | 1973 | 2510 |
| &nbsp;&nbsp;&nbsp;Other accounts receivable and prepaid expenses | 2386 | 3091 |
| &nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 15004 | 20063 |
| &nbsp;&nbsp;&nbsp;Property and equipment, net | 3857 | 22110 |
| Total non-current assets | 23220 | 47774 |
| **TOTAL ASSETS** | $**38181** | $**130280** |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| CURRENT LIABILITIES: |  |  |
| &nbsp;&nbsp;&nbsp;Short term loan | $— | $18008 |
| &nbsp;&nbsp;&nbsp;Trade payables | 1736 | 5602 |
| &nbsp;&nbsp;&nbsp;Other accounts payable and accrued expenses | 7337 | 7966 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | 3637 | 4607 |
| Total current liabilities | 12710 | 36183 |
| NON-CURRENT LIABILITIES: |  |  |
| &nbsp;&nbsp;&nbsp;Warrants liability | 3197 | 41150 |
| &nbsp;&nbsp;&nbsp;Convertible promissory notes | 4830 | 14758 |
| &nbsp;&nbsp;&nbsp;Deferred tax liability |  | 1782 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities | 10694 | 13279 |
| Total non-current liabilities | 18721 | 70969 |
| **TOTAL LIABILITIES** | **31431** | **107152** |
| SHAREHOLDERS' EQUITY: |  |  |
| &nbsp;&nbsp;&nbsp;Ordinary Shares of no par value |  |  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 1010447 | 971018 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (1003697) | (947890) |
| **Total shareholders' equity** | **6750** | **23128** |
| **TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY** | $**38181** | $**130280** |

---

**REE AUTOMOTIVE LTD.**

**Condensed Consolidated Statements of Cash Flows**

**U.S. dollars in thousands (Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Twelve Months Ended** | **Twelve Months Ended** |
|  | **December 31,**<br>**2025** | **December 31,**<br>**2024** |
| <u>Cash flows from operating activities:</u> |  |  |
| Net loss | $(55807) | $(111754) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation | 3090 | 3182 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 5067 | 9585 |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrants liability | (37953) | 22750 |
| &nbsp;&nbsp;&nbsp;Change in fair value of derivative liability | (11751) | 9143 |
| &nbsp;&nbsp;&nbsp;Amortization of discount of convertible promissory note | 883 | 476 |
| &nbsp;&nbsp;&nbsp;Interest expenses | 932 | 872 |
| &nbsp;&nbsp;&nbsp;Decrease (increase) in accrued interest on short-term investments |  | 895 |
| &nbsp;&nbsp;&nbsp;Decrease (increase) in inventory | 3075 | (3412) |
| &nbsp;&nbsp;&nbsp;Decrease (increase) in accounts receivable | (13) | 444 |
| &nbsp;&nbsp;&nbsp;Decrease (increase) in other accounts receivable and prepaid expenses | 5269 | (419) |
| &nbsp;&nbsp;&nbsp;Change in operating lease right-of-use assets and liabilities, net | 1065 | 390 |
| &nbsp;&nbsp;&nbsp;Increase (decrease) in trade payables | (4280) | 1905 |
| &nbsp;&nbsp;&nbsp;Increase (decrease) in other accounts payable and accrued expenses | (1230) | (4956) |
| &nbsp;&nbsp;&nbsp;Increase (decrease) in deferred tax liability | (1782) | 1782 |
| &nbsp;&nbsp;&nbsp;Impairment of long-lived assets | 24716 |  |
| &nbsp;&nbsp;&nbsp;Loss from property and equipment sales and disposals | 9 | 132 |
| Net cash used in operating activities | (68710) | (68985) |
| <u>Cash flows from investing activities:</u> |  |  |
| Purchase of property and equipment | (6305) | (7531) |
| Proceeds from sale of property and equipment | 100 |  |
| Proceeds from short-term investments |  | 43500 |
| Net cash provided by (used in) investing activities | (6205) | 35969 |
| <u>Cash flows from financing activities:</u> |  |  |
| Proceeds from issuance of Ordinary Shares, net | 34361 | 45535 |
| Proceeds from exercise of options and warrants | 1 | 13 |
| Repayment of short term loan | (18000) | (15000) |
| Proceeds from short term loan |  | 18000 |
| Proceeds from issuance of warrants |  | 15000 |
| Net cash provided by financing activities | 16362 | 63548 |
| Increase (Decrease) in cash, cash equivalents and restricted cash | (58553) | 30532 |
| Cash, cash equivalents and restricted cash at beginning of year | 74772 | 44240 |
| **Cash, cash equivalents and restricted cash at end of period** | $16219 | $74772 |

---

**Reconciliation of GAAP Financial Metrics to Non-GAAP**

**U.S. dollars in thousands (except share and per share data) (Unaudited)**

**Reconciliation of Net Loss to Adjusted EBITDA**

---

| | | |
|:---|:---|:---|
|  | **Twelve Months Ended** | **Twelve Months Ended** |
|  | **Dec 31,**<br>**2025** | **Dec 31,**<br>**2024** |
| **Net loss on a GAAP Basis** | $(55807) | $(111754) |
| &nbsp;&nbsp;&nbsp;Financial expenses (income), net | (10658) | 7812 |
| &nbsp;&nbsp;&nbsp;Taxes on income (tax benefit) | (1992) | 2063 |
| &nbsp;&nbsp;&nbsp;Loss (Income) from warrants remeasurement | (37953) | 22750 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 7030 | 6767 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 5067 | 9585 |
| &nbsp;&nbsp;&nbsp;Inventory write-downs and non-recurring expenses related to pause in production (1) | 15936 |  |
| &nbsp;&nbsp;&nbsp;Impairment of long-lived assets (2) | 24716 |  |
| &nbsp;&nbsp;&nbsp;Non-recurring expenses related to reduction-in-force (3) | 2101 |  |
| &nbsp;&nbsp;&nbsp;**Adjusted EBITDA** | $(51560) | $(62777) |

---

(1) Includes inventory write-downs to net realizable value and write-offs
 of inventory that currently has no operational use and one-time costs related to the pause in production.

(2) Impairment charges of long-lived assets and loss from lease termination.

(3) Includes one-time expenses related to reduction-in-force plan.

**Reconciliation of net cash used in operating activities to Free Cash Flow**

Twelve Months Ended Dec 31, 2025 Dec 31, 2024

---

| | | |
|:---|:---|:---|
|  | **Twelve Months Ended** | **Twelve Months Ended** |
|  | **Dec 31,**<br>**2025** | **Dec 31,**<br>**2024** |
| **Net cash used in operating activities** | $(68710) | $(68985) |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (6305) | (7531) |
| **Free Cash Flow** | $(75015) | $(76516) |

---

**Reconciliation of GAAP operating expenses to Non-GAAP operating expenses; GAAP net loss to Non-GAAP net loss, and presentation of Non-GAAP net loss per Share, basic and diluted:**

---

| | | |
|:---|:---|:---|
|  | **Twelve Months Ended** | **Twelve Months Ended** |
|  | **Dec 31,**<br> **2025** | **Dec 31,**<br>**2024** |
| **GAAP operating expenses** | $90136 | $75631 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | (5067) | (9585) |
| &nbsp;&nbsp;&nbsp;Impairment of long-lived assets (2) | (24716) |  |
| &nbsp;&nbsp;&nbsp;Non-recurring expenses related to reduction-in-force (3) | (2101) |  |
| **Non-GAAP operating expenses** | $58252 | $66046 |
| **GAAP net loss** | $(55807) | $(111754) |
| &nbsp;&nbsp;&nbsp;Loss (Income) from warrants remeasurement | (37953) | 22750 |
| &nbsp;&nbsp;&nbsp;Loss (Income) from derivatives remeasurement | (11751) | 9143 |
| &nbsp;&nbsp;&nbsp;Share-based compensation | 5067 | 9585 |
| &nbsp;&nbsp;&nbsp;Inventory write-downs and non-recurring expenses related to pause in production (1) | 15936 |  |
| &nbsp;&nbsp;&nbsp;Impairment of long-lived assets (2) | 24716 |  |
| &nbsp;&nbsp;&nbsp;Non-recurring expenses related to reduction-in-force (3) | 2101 |  |
| **Non-GAAP net loss** | $(57691) | $(70276) |
| Weighted average number of ordinary shares used in computing basic and diluted net loss per share | 32140321 | 15933291 |
| **Non-GAAP basic and diluted net loss per share** | $(1.79) | $(4.41) |

---

(1) Includes inventory write-downs to net realizable value and write-offs
 of inventory that currently has no operational use and one-time costs related to the pause in production.

(2) Impairment charges of long-lived assets and loss from lease termination.

(3) Includes one-time expenses related to reduction-in-force plan.